p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma
about
Epidemiology of esophageal cancerAlterations of the TP53 gene in gastric and esophageal carcinogenesisSignaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionInhibition of nutlin-resistant HDM2 mutants by stapled peptidesAssociation between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosisInfluence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis.CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysisGenetic polymorphism of CCND1 G870A and esophageal cancer susceptibility: A meta-analysis.MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia.Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis.MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis.Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population.
P2860
Q24625927-8120C687-4411-428F-A021-24ABE9EB1172Q26866191-12AAF402-28BF-4ECE-93FA-37A07065E6EFQ27026253-DD2B8453-CC34-4EAE-B05A-DF03BDCA9085Q27301404-D0D44B82-71D0-4106-9CC1-9096F90EB5A7Q34763711-58BA256D-4909-40E3-B951-527A714B40A2Q34848523-2760FC24-E7A3-4244-AC1F-A0AFC7E4C370Q37344537-8195E3CE-ADCB-4015-A30E-0214C02068E0Q38221502-23CF5ACD-E4FC-430D-B8C0-0E4F2116B66BQ38291890-6CBA2F1D-16EB-4F0E-B602-25C96B4142D1Q38396084-683CD260-5A5D-4938-B63A-290FE48B90DAQ40382596-CBEC6927-D03D-49DB-AAE4-94006A00BF89Q41143120-363007BD-C20E-4D47-88A6-B3F30E4AD81EQ42430422-E27C0AFE-D075-4003-90F4-9A4D94CAA40FQ43209967-689925CD-5DDF-4379-A07D-F3265929F76EQ53226854-2C451336-BBDF-42C9-A679-10A4E2B0135F
P2860
p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@ast
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@en
type
label
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@ast
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@en
prefLabel
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@ast
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@en
P2093
P2860
P1476
p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma
@en
P2093
D C Christiani
D W Cescon
K Asomaning
P2860
P356
10.1111/J.1442-2050.2009.00960.X
P50
P577
2009-03-17T00:00:00Z